Pfizer expands in Brazil

Pfizer Inc. (NYSE:PFE) will acquire a 40% stake in Brazilian generics company Laboratorio Teuto Brasileiro S.A. (Anapolis, Brazil) as part of a deal under which Pfizer will gain rights to commercialize Teuto's products in Brazil and other countries under Pfizer's own brands. Products include branded and unbranded generics in areas such as pain and inflammation, and cardiovascular, anti-infectives, CNS and respiratory diseases. Teuto also will have rights to commercialize certain Pfizer products under Teuto's own brand in Brazil. ...